2023
DOI: 10.1542/peds.2021-053663
|View full text |Cite
|
Sign up to set email alerts
|

Pseudomonas Meningitis and Intracranial Hemorrhage in IRAK-4 Deficiency

Abstract: Interleukin-1 receptor-associated kinase 4 (IRAK-4) deficiency is a primary immune deficiency of the innate immune system. Children with this condition are susceptible to life-threatening bacterial infections. IRAK-4 deficiency results in reduced or absent systemic features of inflammation despite overwhelming infection. We present 2 siblings who died in infancy after rapidly progressive Pseudomonas sepsis and meningitis. There was diagnostic uncertainty in the firstborn infant because of significant intracran… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Considering accumulating observations in patients with IRAK-4 de ciency, mainstay treatment for this disease includes immunoglobulin replacement by IV (IVIG) or subcutaneous (SCIG) along with prophylactic antibiotic therapy [38]. In the absence of current information, IgG replacement therapy may need to last a lifetime [15]. The use of empiric antibiotics in the treatment of IRAK4-de cient patients calls for consideration of potential antibiotic resistance in addition to the requirement for broad-spectrum coverage, which covers not only common organisms, such as S. pneumococcus and S. aureus, but also, some uncommon gram-negative strains, such as P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering accumulating observations in patients with IRAK-4 de ciency, mainstay treatment for this disease includes immunoglobulin replacement by IV (IVIG) or subcutaneous (SCIG) along with prophylactic antibiotic therapy [38]. In the absence of current information, IgG replacement therapy may need to last a lifetime [15]. The use of empiric antibiotics in the treatment of IRAK4-de cient patients calls for consideration of potential antibiotic resistance in addition to the requirement for broad-spectrum coverage, which covers not only common organisms, such as S. pneumococcus and S. aureus, but also, some uncommon gram-negative strains, such as P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, P. aeruginosa infection coupled with a poor acute phase may be the initial sign of a potential primary immune de ciency (PID), especially defects in TLR1 signaling pathways such as IRAK-4 de ciency [10,14]. Actually, children with P. aeruginosa sepsis have been identi ed along with IRAK-4 de ciency in a few cases [10,13,15].…”
Section: Introductionmentioning
confidence: 99%